During the 2022 Critical Care Congress, Karin Reuter-Rice, PhD, NP, FAAN, FCCM, will talk about precision health, and specifically the role omic technologies play in critical care in a thought leader session titled "Genetics and Genomics."
The Centers for Disease Control and Prevention defines precision health as knowing that unique disease risks, the approaches to take to protect health, and interventions can be tailored to an individual rather than using the same approach for everyone.
1 Karin Reuter-Rice, PhD, NP, FAAN, FCCM, says that precision health is the future of healthcare and that critical care professionals play an important role in its implementation. “Critical care professionals strive to provide the ‘right care’ for each critically ill and injured patient, which includes the use of precision health.”
Dr. Reuter-Rice is an associate professor at Duke University’s School of Nursing, School of Medicine, and Institute for Brain Sciences. She is also an acute care pediatric nurse practitioner with Duke’s Division of Critical Care Medicine. Dr. Reuter-Rice was the 2020 recipient of the Norma J. Shoemaker Award for Nursing Excellence. SCCM recognized her for demonstrating excellence in nursing critical care, clinical practice, education, and/or administration. During the 2022 Critical Care Congress, she will talk about precision health, and specifically the role omic technologies play in critical care in a thought leader session titled “Genetics and Genomics.”
Omics are scientific fields—such as genomics, transcriptomics, metabolomics, proteomics, and lipidomics—that measure and analyze biological molecules and apply them to a biological system.
2 In Dr. Reuter-Rice’s session, she will examine the current landscape of omics, including the role of genetics and genomics in critical care. She also will reflect on the successes, challenges, and opportunities that come with adopting precision health technologies in the care of critically ill and injured patients.
Dr. Reuter-Rice is excited by new ways precision health approaches are being leveraged in critical care and across care settings to improve patient-driven interventions. She is interested in how these new approaches can scale in a way that would allow more marginalized communities across the country and around the world to significantly reduce intensive care unit morbidity and mortality.
She hopes that Congress attendees leave her session with a sense of excitement for what lies ahead in critical care and a better understanding of how they can become more engaged in precision health initiatives, both within SCCM and at the patient level. “Genetics and genomics are just one part of precision health and offer potential new keys to help unlock effective high-quality care for our patients.”
Dr. Reuter-Rice is one of many thought leaders who will be presenting during the 2022 Critical Care Congress, which is now being held virtually Monday, April 18 through Thursday, April 21, 2022!
Join SCCM for the 2022 Critical Care Congress and dive into the latest knowledge and research with livestreamed sessions, interactive opportunities, and content access for one year. Learn More |
References
- Centers for Disease Control and Prevention. Precision health: improving health for each of us and all of us. Page last reviewed August 14, 2020. Accessed December 15, 2021. https://www.cdc.gov/genomics/about/precision_med.htm
- Chapter 2. Omics-based clinical discovery: science, technology, and applications. In: Committee on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials; Board on Health Care Services; Board on Health Sciences Policy; Institute of Medicine; Micheel CM, Nass SJ, Omenn GS, ed. Evolution of Translational Omics: Lessons Learned and the Path Forward. National Academies Press; 2012. https://www.ncbi.nlm.nih.gov/books/NBK202165/
